Patient-reported pain severity, pain interference and health status in HR+/HER2− advanced/metastatic breast cancer

por Wood, Robert, Mitra, Debanjali, de Courcy, Jonathan, Iyer, Shrividya
Publicado 2017

Systematic review and network meta-analysis comparing palbociclib with chemotherapy agents for the treatment of postmenopausal women with HR-positive and HER2-negative advanced/met...

por Wilson, Florence R., Varu, Abhishek, Mitra, Debanjali, Cameron, Chris, Iyer, Shrividya
Publicado 2017

Real-World Palbociclib Use in HR+/HER2− Advanced Breast Cancer in Canada: The IRIS Study

por Mycock, Katie, Zhan, Lin, Taylor-Stokes, Gavin, Milligan, Gary, Mitra, Debanjali
Publicado 2021

Association between oral 5-ASA adherence and health care utilization and costs among patients with active ulcerative colitis

por Mitra, Debanjali, Hodgkins, Paul, Yen, Linnette, Davis, Keith L, Cohen, Russell D
Publicado 2012

Real-World Treatment Patterns and Clinical Outcomes in Patients Receiving Palbociclib for Hormone Receptor–Positive, Human Epidermal Growth Factor Receptor 2–Negative Advanced or M...

por Waller, John, Mitra, Debanjali, Mycock, Katie, Taylor-Stokes, Gavin, Milligan, Gary, Zhan, Lin, Iyer, Shrividya
Publicado 2019

Management of ADHD in children across Europe: patient demographics, physician characteristics and treatment patterns

por Hodgkins, Paul, Setyawan, Juliana, Mitra, Debanjali, Davis, Keith, Quintero, Javier, Fridman, Moshe, Shaw, Monica, Harpin, Valerie
Publicado 2013

Symptom burden and splenomegaly in patients with myelofibrosis in the United States: a retrospective medical record review

por Mitra, Debanjali, Kaye, James A, Piecoro, Lance T, Brown, Jennifer, Reith, Kelly, Mughal, Tariq I, Sarlis, Nicholas J
Publicado 2013

A prospective observational study of patient-reported functioning and quality of life in advanced and metastatic breast cancer utilizing a novel mobile application

por Richardson, David, Zhan, Lin, Mahtani, Reshma, McRoy, Lynn, Mitra, Debanjali, Reynolds, Maria, Odom, Dawn, Hollis, Kelly, Kaye, James A., Jones, Cheryl, Hargis, Jeffrey
Publicado 2021

Population-based recurrence rates among older women with HR-positive, HER2-negative early breast cancer: Clinical risk factors, frailty status, and differences by race

por Zhou, Jifang, Cueto, Jenilee, Ko, Naomi Y., Hoskins, Kent F., Nabulsi, Nadia A., Asfaw, Alemseged A., Hubbard, Colin C., Mitra, Debanjali, Calip, Gregory S., Law, Ernest H.
Publicado 2021

Impact of time to distant recurrence on breast cancer-specific mortality in hormone receptor-positive breast cancer

por Calip, Gregory S., Nabulsi, Nadia A., Hubbard, Colin, Asfaw, Alemseged A., Lee, Inyoung, Zhou, Jifang, Cueto, Jenilee, Mitra, Debanjali, Ko, Naomi Y., Hoskins, Kent F., Law, Ernest H.
Publicado 2022

Health-related Quality of Life in Hormone Receptor-Positive Early Breast Cancer: Analyses From the Surveillance, Epidemiology, and End Results Medicare Health Outcomes Survey

por Nabulsi, Nadia A, Naing, Khatija W, Deng, Huiwen, Cueto, Jenilee, Asfaw, Alemseged A, Hubbard, Colin C, Zhou, Jifang, Lee, Inyoung, Mitra, Debanjali, Calip, Gregory S, Law, Ernest H
Publicado 2022

Real-World Treatment Patterns and Clinical Effectiveness of Palbociclib Plus an Aromatase Inhibitor as First-Line Therapy in Advanced/Metastatic Breast Cancer: Analysis from the US...

por Law, Jeanna Wallenta, Mitra, Debanjali, Kaplan, Henry G., Alfred, Tamuno, Brufsky, Adam M., Emir, Birol, McCracken, Haley, Liu, Xianchen, Broome, Ronda G., Zhang, Chenan, DiCristo, Caroline, Chen, Connie
Publicado 2022